SDC

Executive Summary

SDC is a technology-enabled Contract Research Organization (CRO) founded in 2005 and headquartered in San Diego, California. The company provides comprehensive clinical trial services integrated with proprietary software solutions for eSource, ePRO, EDC, and IRT, all powered by an AI-driven analytics platform. Its mission is to empower better clinical decisions through real-time data capture and insights. As a private company operating in the diagnostics space, SDC differentiates itself by combining traditional CRO capabilities with advanced data analytics and software tools. This integrated approach aims to streamline trial operations, reduce timelines, and improve data quality for sponsors. While SDC has a focused niche, its market position is supported by the growing demand for decentralized and data-driven clinical trials. However, as a private entity with limited public disclosures, visibility into its financial performance and growth trajectory is constrained. The company's long-term success hinges on its ability to secure large contracts, expand its technology platform, and maintain competitive differentiation in an increasingly crowded CRO market.

Upcoming Catalysts (preview)

• Q3 2026Announcement of major pharmaceutical partnership60% success
• Q4 2026Launch of next-generation AI analytics platform55% success
• Q1 2027Expansion into new therapeutic areas through strategic acquisition40% success